ORIGINAL RESEARCH
Published on 21 May 2026
Adverse neurological events associated with bispecific T cell engagers in oncology: a real-world study
doi 10.3389/fphar.2026.1819689
- 585 views
- Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Development and Assessment of Immunogenic Agents for Cancer Therapy
Development and Assessment of Immunogenic Agents for Cancer Therapy
1,827
Total downloads
11k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
BRIEF RESEARCH REPORT
Accepted on 15 May 2026
Pilot Study of Topical Imiquimod Combined with Pembrolizumab for Unresectable Cutaneous Metastatic Melanoma
- 946 views
MINI REVIEW
Published on 21 Apr 2026
Key immune checkpoint inhibitor-associated toxicities: from molecular mechanisms to clinical management
doi 10.3389/fphar.2026.1810121
- 786 views
SYSTEMATIC REVIEW
Published on 04 Mar 2026
Efficacy and safety of immune checkpoint inhibitors combined with chemoradiotherapy in locally advanced cervical cancer: a systematic review and meta-analysis
doi 10.3389/fphar.2026.1766157
- 908 views
ORIGINAL RESEARCH
Published on 03 Feb 2026
Immunotherapy and tyrosine kinase inhibitors in chordoma: a real-world data study from a European Reference Network on Rare Adult Solid Cancers member center
doi 10.3389/fonc.2026.1755538
- 1,627 views
SYSTEMATIC REVIEW
Published on 15 Oct 2025
Evaluating the efficacy and safety of tebentafusp in the treatment of metastatic uveal melanoma: a 2025 update systematic review and meta-analysis
doi 10.3389/fonc.2025.1667282
- 3,551 views
- 5 citations
Published in
Frontiers in Oncology
Pharmacology of Anti-Cancer Drugs
Other participating journals
Frontiers in Pharmacology
- 4.8 impact factor
- 8.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: